Skip Navigation

European Heart Journal 2002 23(7):509-511; doi:10.1053/euhj.2001.3026
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by St. John Sutton, M.
Right arrow Articles by Scott, C.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by St. John Sutton, M.
Right arrow Articles by Scott, C.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

A prediction rule for left ventricular dilatation post-MI?

M. St. John Sutton and C.H. Scott

University of Pennsylvania Medical Center, Philadelphia, PA, U.S.A.

References

  1. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51[Abstract/Free Full Text]
  2. Pfeffer MA, Pfeffer JM, Lamas GA. Development and prevention of congestive heart failure following myocardial infarction. Circulation. 1993;87:IV120–IV125
  3. Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–677[Abstract]
  4. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993;87:755–763[Abstract/Free Full Text]
  5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81:1161–1172[Abstract/Free Full Text]
  6. St. John Sutton M, Pfeffer MA, Plappert T. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 1994;89:68–75[Abstract/Free Full Text]
  7. St. John Sutton M, Pfeffer MA, Moyé L. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Baseline predictors of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) trial. Circulation. 1997;96:3294–3299[Abstract/Free Full Text]
  8. N Engl J Med. 1992;327:678–685[Abstract]
  9. Sharpe N, Murphy J, Smith H, Hannan S. Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction. Eur Heart J. 1990;11:147–156
  10. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406–412[Abstract/Free Full Text]
  11. de Kam PJ, Nicolosi GL, Voors AA. Prediction of six months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality: application of a new dilatation model to GISSI-3 data. Eur Heart J. 2002;23:536–542[Abstract/Free Full Text]
  12. de Kam PJ, Voors AA, van den Berg MP. Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol. 2000;36:2047–2053[Abstract/Free Full Text]
  13. Lancet. 1994;343:1115–1122[Web of Science][Medline]
  14. van Gilst WH, Kingma JH, Peels KH, Dambrink JH, St. John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 1996;28:114–121[Abstract]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by St. John Sutton, M.
Right arrow Articles by Scott, C.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by St. John Sutton, M.
Right arrow Articles by Scott, C.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?